Mark Dowling is currently the Head of External Innovation in Immunology at Sanofi Genzyme. Previously, they held leadership roles at Kaleido Biosciences and Novartis Institutes for BioMedical Research, including Senior Director and Senior Investigator II, where they contributed to significant advancements in pharmacology and drug discovery. Mark earned a Ph.D. in GPCR Pharmacology from the University of Leicester in 2003, establishing a strong foundation for their extensive experience in the pharmaceutical industry.
This person is not in the org chart
This person is not in any teams
This person is not in any offices